Rivastigmine
Brand name: Rivastigmine
Rank #333 of 500 drugs by total cost
$31.4M
Total Cost
118,567
Total Claims
$31.4M
Total Cost
4,295
Prescribers
$265
Cost per Claim
11,704
Beneficiaries
158,895
30-Day Fills
$7,321
Avg Cost/Provider
28
Avg Claims/Provider
About Rivastigmine
Rivastigmine (sold as Rivastigmine) was prescribed 118,567 times by 4,295 Medicare Part D providers in 2023, costing the program $31.4M. At $265 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 330 | Methotrexate Sodium (Methotrexate) | $32.4M | 911,965 |
| 331 | Bumetanide (Bumetanide) | $32.4M | 735,077 |
| 332 | Voxelotor (Oxbryta) | $31.5M | 2,707 |
| 333 | Rivastigmine (Rivastigmine) | $31.4M | 118,567 |
| 334 | Zolpidem Tartrate (Zolpidem Tartrate) | $31.3M | 3,144,599 |
| 335 | Lorazepam (Lorazepam) | $31.3M | 3,237,827 |
| 336 | Diphth,pertuss(Acell),tet Vac (Boostrix Tdap) | $31.2M | 466,555 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology